SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial.
- Published In:
- Human reproduction (Oxford, England), 40(7), 1357-1365 (2025)
- Authors:
- Chi, Hongbin, Song, Ying, Jin, Lei, Song, Xueru, Wang, Xiaohong, Ma, Qianhong, Cao, Yunxia, Liang, Xiaoyan, Tan, Jichun, Guan, Yichun, Diao, Feiyang, Li, Yanping, Li, Zeli, Sun, Yuqi, Shu, Chang, Chen, Hong, Shen, Kai, Qiao, Jie
- Database ID:
- RPEP-10451
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10451APA
Chi, Hongbin; Song, Ying; Jin, Lei; Song, Xueru; Wang, Xiaohong; Ma, Qianhong; Cao, Yunxia; Liang, Xiaoyan; Tan, Jichun; Guan, Yichun; Diao, Feiyang; Li, Yanping; Li, Zeli; Sun, Yuqi; Shu, Chang; Chen, Hong; Shen, Kai; Qiao, Jie. (2025). SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial.. Human reproduction (Oxford, England), 40(7), 1357-1365. https://doi.org/10.1093/humrep/deaf082
MLA
Chi, Hongbin, et al. "SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial.." Human reproduction (Oxford, 2025. https://doi.org/10.1093/humrep/deaf082
RethinkPeptides
RethinkPeptides Research Database. "SHR7280, an oral gonadotropin-releasing hormone antagonist, ..." RPEP-10451. Retrieved from https://rethinkpeptides.com/research/chi-2025-shr7280-an-oral-gonadotropinreleasing
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.